The National Medical Products Administration conditionally approved the listing of purchaseolone saline injection

Recently, the National Medical Products Administration approved the conditional market approval of Precise Biotechnology Co., Ltd. in Chongqing for its Poliomyelitis Inoculation Injection, which is used to treat difficult-to-treat or relapsed acute B-cell lymphocytic leukemia patients aged 3 to 21 years old with CD19 positivity. The approval of this product provides a new treatment option for relevant patients.